Your browser doesn't support javascript.
loading
Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/ß = 2 Gy overestimates the RBE.
Eichkorn, Tanja; Karger, Christian P; Brons, Stephan; Koerber, Stefan Alexander; Mielke, Thomas; Haberer, Thomas; Debus, Juergen; Herfarth, Klaus.
Affiliation
  • Eichkorn T; Department of Radiation Oncology, Heidelberg University Hospital, Germany; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg,
  • Karger CP; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Germany; Dept. of Medical Physics in Radiation Oncology, German Cancer Research Center, Heidelberg, Germany. Electronic address: c.karger@dkfz.de.
  • Brons S; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Germany. Electronic address: Stephan.Brons@med.uni-heidelberg.de.
  • Koerber SA; Department of Radiation Oncology, Heidelberg University Hospital, Germany; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg,
  • Mielke T; Department of Radiation Oncology, Heidelberg University Hospital, Germany; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany. Electronic address: thomas.mielke@med.uni-heidelberg.de.
  • Haberer T; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Germany; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany. Electronic address: Thomas.Haberer@med.uni-heidelberg.de.
  • Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Germany; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology (E050), G
  • Herfarth K; Department of Radiation Oncology, Heidelberg University Hospital, Germany; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg,
Radiother Oncol ; 173: 223-230, 2022 08.
Article in En | MEDLINE | ID: mdl-35714806
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Heavy Ion Radiotherapy Type of study: Clinical_trials / Observational_studies Limits: Humans / Male Language: En Journal: Radiother Oncol Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Heavy Ion Radiotherapy Type of study: Clinical_trials / Observational_studies Limits: Humans / Male Language: En Journal: Radiother Oncol Year: 2022 Type: Article